Cytokinetics to Host Investor Call on December 27 to Discuss the Topline Results from SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in...
Rhea-AI Impact
Rhea-AI Sentiment
(Negative)
Rhea-AI Summary
Cytokinetics, Incorporated (Nasdaq: CYTK) to discuss topline results from pivotal Phase 3 clinical trial of aficamten in patients with symptomatic obstructive...
Coherus Announces FDA Approval of UDENYCA ONBODY™, a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv | CHRS Stock News
Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
Rhea-AI Summary
Coherus BioSciences, Inc. (Nasdaq: CHRS) announced FDA approval of UDENYCA ONBODY, an on-body injector for pegfilgrastim, with a unique retractable needle...
Albertsons Companies to Release Third Quarter Fiscal 2023 Earnings on January 9, 2024 | ACI Stock News
Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
Albertsons Companies, Inc. (NYSE: ACI) will release its financial results for the third quarter of fiscal year 2023, which ended December...
SomaLogic Issues Statement Correcting Madryn Asset Management’s Misleading Disclosure | LAB Stock News
SomaLogic Publishes Key Correspondence from LabCorp CEO Omitted by Madryn in its Attempt to Undermine Confidence in SomaLogic's Thorough Strategic Process
Reiterates Value-Maximizing Transaction with...
Riverview Bancorp Declares Quarterly Cash Dividend of $0.06 Per Share | RVSB Stock News
Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
Riverview Bancorp, Inc. (RVSB) announces a quarterly cash dividend of $0.06 per share, unchanged from the previous quarter. The dividend will...
